Chlamydia trachomatis is a sexually transmitted disease (STD) commonly diagnosed in pregnancy. C. trachomatis has been linked to several pregnancy complications including premature rupture of membranes (PROM), preterm labor and birth, low birth weight, intrauterine growth retardation, and postpartum endometritis. Infants born to mothers through an infected birth canal are at risk for acquiring C. trachomatis pneumonitis, conjunctivitis, and nasopharyngeal infection. The standard treatment of C. trachomatis in pregnancy is erythromycin. Recently, amoxicillin and clindamycin have been added as alternative regimens for those patients intolerant of erythromycin. This paper reviews the effectiveness and tolerance of the alternative regimens compared with erythromycin and the success of antepartum treatment of chlamydia in preventing the poor pregnancy outcome and neonatal morbidity associated with C. trachomatis. (C) 1995 Wiley-Liss, Inc.
able sexually transmitted disease (STD) in the United States. 1'2 C. trachomatis is a well-known cause of pelvic inflammatory disease and cervicitis in women. The prevalence of chlamydia in pregnant women ranges from 2 to 30%. 3-s Certain women are at increased risk: those receiving care at public health clinics, being of young age (<25 years), being of nonwhite race, being of low parity, having multiple sexual partners, having had a new sexual partner in the preceding 3 months, using oral contraception, not using barrier contraception, and having other STDs or a history of other STDs. 3's'6 In pregnant women, C. trachomatis infection carries additional risks compared with nonpregnant women. The risks of C. trachomatis in pregnancy and the newborn have recently been reviewed. Although conflicting data exist, maternal C. trachomatis infection has several potential antenatal complications including premature rupture of membranes (PROM), preterm labor and birth, low birth weight, intrauterine growth retardation, and stillbirth 3'6-1 as well as postpartum and postabortal endometritis. [11] [12] [13] [14] Following passage through an infected birth canal, infants have a significant risk of acquiring C. trachomatis pneumonitis (3-18%), conjunctivitis (18-50%) , and nasopharyngeal infection (15--20% Ryan et al. 6 prospectively followed 2,433 chlamydia-culture-positive and 9,1 culture-negative pregnant women. Of the C. trachomatis-infected women, 1,1 10 remained untreated throughout the pregnancy, whereas 1,323 received treatment until subsequent cultures were negative. There was a significant increase in the incidence of PROM and low-birth-weight infants and a decrease in neonatal survival in the untreated group compared with the treated group. No such differences were noted in the treated group compared with the culture-negative group. No significant difference in the incidence of chorioamnionitis was found in any of the groups. This study provides evidence that the treatment of C. trachomatis prior to delivery decreases the incidence of poor pregnancy outcome. The strength of this study over the previous study by Cohen et 
